Literature DB >> 6180750

Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation.

G Singh, K W Renton, N Stebbing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180750     DOI: 10.1016/0006-291x(82)91247-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  6 in total

Review 1.  Problems in pharmacokinetic investigations in patients with HIV infection.

Authors:  J D Unadkat; J M Agosti
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Depression of drug metabolizing activity in the human liver by interferon-alpha.

Authors:  H Okuno; Y Kitao; M Takasu; H Kano; K Kunieda; T Seki; Y Shiozaki; Y Sameshima
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

4.  Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat.

Authors:  C K Svensson; P W Knowlton
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

5.  Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients.

Authors:  B C Israel; R A Blouin; W McIntyre; S I Shedlofsky
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

6.  Alpha interferon has no effect on lidocaine metabolism in the rat.

Authors:  E Melzer; E Bardan; I Ronen; Z Krepel; S Bar Meir
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.